Skip to content
StockResearch
ABT/History

Abbott Laboratories (ABT) valuation history

$102.51

Latest weekly close · Market cap $179.1B

Share ABT P/E history

Share ABT P/E history

Preview the embed

Chart by stockresearch.app. Reuse with credit under CC BY 4.0.

Within its usual range

As of

ABT's P/E of 28.6x is lower than 51% of its weekly readings over the last five years.

Weekly P/E with its 5-year range

P/E each weekMiddle half of the last 5 years5-year median 28.8×
P/E weekly history10×20×30×40×50×28.6×20222023202420252026
5-year median
28.8×
10-year median
36.6×
5-year low to high
13.5×–41.0×
Versus 5-year median
-1%

P/E

49thpercentile

of its weekly readings over the last five years

Within its usual range

Growth, last 12 months vs the year before

Revenue
+7%accelerating
EPS
-54%

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading
010020030020222023202420252026

P/E at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

ABT P/E at each year-end
Year-endP/E5-year percentile
15.6×1
34.6×48
37.4×52
24.8×8
34.9×6
57.9×65
46.7×49
141.9×87
44.9×84
42.2×97

Loading peers and related research…

About this history

What is ABT's current P/E?
ABT's P/E of 28.6x is lower than 51% of its weekly readings over the last five years.
What is ABT's five-year median P/E?
28.8x. Half of ABT's weekly readings over the last five years were higher and half were lower. This page has 720 weekly readings, from Jan 7, 2013 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?
No. The rank compares ABT only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Source: SEC company filings and weekly market prices. Multiples use the last twelve months of financial results. Updated .

How the valuation data is built